[1st results of the intra-articular use of Zymofren (N.D.) in rheumatology].
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002918:Chymotrypsin / Q000627:therapeutic use*; D005341:Fibrinolysin / Q000627:therapeutic use*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D011379:Prognosis; D014357:Trypsin / Q000627:therapeutic use*
D000700:Analgesics; D010455:Peptides; D002918:Chymotrypsin; D014357:Trypsin; D005341:Fibrinolysin
Premiers résultats de l'emploi intra-articulaire du Zymofren (N.D.) en rhumatologie.